2016-07-08 16:36
Li Sirui: the Internet or break the drawbacks of traditional Chinese herbal medicines
 [straight news network Beijing on July 8 news] (Tasly) Tasly Group Holdings strategic development department general manager, Tasly health industry fund risk committee Si Rui Li think, via the Internet is likely to gradually break the traditional medicine transaction mode value chain length, across the industry, low degree of standardization, information opacity and other problems.
Internet or break the traditional Chinese herbal medicine trade drawbacks
Tasly group holdings development strategy, general manager of the Department, Tasly health industry fund risk committee Si Rui Li think, traditional Chinese medicine standardization problem limits it to the world, but with the relative, the overseas market of traditional Chinese medicine has large demand, and the demand is increasing. In solving scheme, Si Rui Li mentioned the Internet platform, he thinks via the Internet is likely to gradually break the traditional Chinese herbal medicines trading patterns exist long value chain, multi industry, the degree of standardization across the low, information opacity problem.
Standardization problem of traditional Chinese Medicine
In the course of the development of Chinese medicine, there is a very core issue, that is, the standardization of traditional Chinese medicine and heritage. Because the traditional Chinese medicine is an empirical science to carry on, so the efficiency is relatively low.
Referred to Chinese medicine, certainly can not be separated from traditional Chinese medicine. And the traditional Chinese medicine in the process of syndrome differentiation and treatment of traditional Chinese medicine can not be separated from. Many Chinese medicine through the extraction of a variety of ingredients produced in the process of extraction of a variety of medicinal herbs, standardization is difficult to control, which is a major cause of the difficulties of traditional Chinese medicine to the international.
If in accordance with the standards of Western medicine to interpret Chinese traditional medicine, from pharmaceutical companies in the cultivation, processing and extraction of whole industry chain should have the corresponding standard. Tasly through 20 years of development and exploration, in the global industrial chain in the standard of traditional Chinese medicine has accumulated a lot of experience.
Li Sirui said that the source of a big challenge to the upstream international Tasly standardization of herbal medicines. From extraction to preparation, can be achieved through standard equipment, technological innovation, so there is a compound Danshen Dripping Pills in the United States to do the three phase of clinical trials FDA. However, the standardization of Chinese herbal medicine still need to crack the problem, which is restricting the development of Chinese herbal medicine through the electricity business model to expand the market a big challenge.
Overseas markets have a large demand for traditional Chinese Medicine
Li Sirui said, in fact, overseas demand for Chinese medicine is increasing. Especially in the Chinese region of Southeast Asia, Europe, Australia, they have a great demand for plant extracts, Chinese herbal pieces, traditional Chinese medicine particles.
Two years ago, the investment of a family doctor group in australia. "The family physician group to cooperate with us to the demands of a point is that Tasly to take China's traditional Chinese medicine treatment means to Australia, and they form a mode of combination of Chinese traditional and Western medicine."
Second, from the point of view of supply and demand, China's global market share of Chinese herbal medicines is not high. On the one hand because of the overseas quality standards for medicinal materials is very high; on the other hand, a lot of endangered species is difficult to achieve large-scale cultivation. This kind of medicinal material needs to make a breakthrough in the technology, realize the artificial.
Therefore, Li Sirui believes that in the long term in the supply and demand of Chinese herbal medicine is in the state of imbalance, especially the supply side can not keep up with the demand side of the growth needs.
But if we can solve problem of standard for the traditional Chinese medicine, quality control problems to solve Chinese herbal medicine in the circulation process source clear, reliable, and have the right to determine the price of a product in the international market, domestic Chinese herbal medicine is expected to in the world occupies a place.
In addition, the domestic enterprises have not established their own marketing channels in overseas markets, so, through the Internet to expand overseas Chinese herbal pieces of cross-border electricity suppliers is also a trend in the future.
Challenge and way out of traditional Chinese herbal medicine trade pattern
Farmers planting Chinese herbal medicine because of information asymmetry is very difficult to make money, and traditional Chinese medicine trade, processing to final sales across the agricultural, industrial, information, and other industry, but traditional Chinese herbal medicine market mode heritage for thousands of years down almost no too big change.
In addition, the Chinese herbal medicine trade is an acquaintance of the economic circle, dealers rely on their own network to build a marketing network, is a network of economic, and a monopoly. Farmers because they can not find the complete information on the demand for the terminal, so the supply and demand in the short term extreme imbalance, resulting in the price of some medicinal herbs plummeted.
The whole market of Chinese herbal medicines, Chinese herbal medicine through layers of reselling to enter the terminal. Among them, 60% in industrial pharmaceutical companies made traditional Chinese medicine or health care products; and 10% as a health or food, that is to say, retail terminal for food or pharmacy; and 30% of admission to the hospital.
|